Preclinical studies revealed a major role of the stimulator of interferon genes (STING) pathway, a cytosolic DNA sensor, as a crucial event required for optimal type I interferon production, dendritic cell activation, and priming of CD8+ T cells against tumor-associated antigens [11,12]. The gene discussed is STING1; the disease is neoplasm.